Evotec
Soumya Katamani has extensive experience in the field of neuroscience and molecular biology, currently serving as a Senior Research Assistant at Evotec since May 2017, where responsibilities include assay development and designing high content imaging assays for compound screening. Previous roles include Research Assistant positions at Evotec and Grenoble Institut des Neurosciences, focusing on in vitro disease models and live cell imaging of neuronal behavior. Soumya's academic background includes a Master's degree in Molecular Biology from Umeå University and a Bachelor's degree in Genetic Engineering from SRM University, alongside a PhD graduate student experience at Institut Curie, where research centered on nanobodies targeting the Huntingtin protein.
This person is not in the org chart
This person is not in any teams
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.